terça-feira, 6 de fevereiro de 2018
Parkinson’s Institute and Clinical Center Collaborates with Merck to Evaluate LRRK2 Kinase Inhibition in Preclinical Model of Parkinson’s Disease
February 05, 2018 - Parkinson’s Institute and Clinical Center Collaborates with Merck to Evaluate LRRK2 Kinase Inhibition in Preclinical Model of Parkinson’s Disease
Assinar:
Postar comentários (Atom)
Nenhum comentário:
Postar um comentário
Publicidades não serão aceitas.